IL-17A acts as a pathogenic cytokine in a variety of inflammatory diseases, including multiple sclerosis [26, 27], inflammatory bowel disease [29, 30], and uveitis [63–66]. This evidence concerns the gene IL17A and inflammatory bowel disease.